Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Stanbury

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
European Heart Journal|March 3, 2021
Transforming clinical research by involving and empowering patients- the RATE-AF randomized trialKarina V Bunting, Mary Stanbury, Otilia Tica, et al.
European Heart Journal|January 31, 2019
Digital learning and the future cardiologistXavier Rosselló, Mary Stanbury, Ronen Beeri, et al.
Heart (British Cardiac Society)|January 17, 2025
Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) randomised trialZainab Abdali, Karina V Bunting, Samir Mehta, et al.
Cardiology|August 31, 2020
Importance and Assessment of Quality of Life in Symptomatic Permanent Atrial Fibrillation: Patient Focus Groups from the RATE-AF TrialJacqueline Jones, Mary Stanbury, Sandra Haynes, et al.
European Journal of Heart Failure|September 2, 2025
Low-dose digoxin improves cardiac function in patients with heart failure, preserved ejection fraction and atrial fibrillation - the RATE-AF randomized trialKarina V Bunting, Asgher Champsi, Simrat K Gill, et al.
BMJ Open|July 22, 2017
A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trialDipak Kotecha, Melanie Calvert, Jonathan J Deeks, et al.
Nature Medicine|July 15, 2024
Consumer wearable devices for evaluation of heart rate control using digoxin versus beta-blockers: the RATE-AF randomized trialSimrat K Gill, Andrey Barsky, Xin Guan, et al.
Heart (British Cardiac Society)|March 11, 2021
Improving the diagnosis of heart failure in patients with atrial fibrillationKarina V Bunting, Simrat K Gill, Alice Sitch, et al.
JAMA|December 22, 2020
Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical TrialDipak Kotecha, Karina V Bunting, Simrat K Gill, et al.
European Heart Journal|January 11, 2023
Artificial intelligence to enhance clinical value across the spectrum of cardiovascular healthcareSimrat K Gill, Andreas Karwath, Hae-Won Uh, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Heart Journal|March 3, 2021
Transforming clinical research by involving and empowering patients- the RATE-AF randomized trialKarina V Bunting, Mary Stanbury, Otilia Tica, et al.
European Heart Journal|January 31, 2019
Digital learning and the future cardiologistXavier Rosselló, Mary Stanbury, Ronen Beeri, et al.
Heart (British Cardiac Society)|January 17, 2025
Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) randomised trialZainab Abdali, Karina V Bunting, Samir Mehta, et al.
Cardiology|August 31, 2020
Importance and Assessment of Quality of Life in Symptomatic Permanent Atrial Fibrillation: Patient Focus Groups from the RATE-AF TrialJacqueline Jones, Mary Stanbury, Sandra Haynes, et al.
European Journal of Heart Failure|September 2, 2025
Low-dose digoxin improves cardiac function in patients with heart failure, preserved ejection fraction and atrial fibrillation - the RATE-AF randomized trialKarina V Bunting, Asgher Champsi, Simrat K Gill, et al.
BMJ Open|July 22, 2017
A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trialDipak Kotecha, Melanie Calvert, Jonathan J Deeks, et al.
Nature Medicine|July 15, 2024
Consumer wearable devices for evaluation of heart rate control using digoxin versus beta-blockers: the RATE-AF randomized trialSimrat K Gill, Andrey Barsky, Xin Guan, et al.
Heart (British Cardiac Society)|March 11, 2021
Improving the diagnosis of heart failure in patients with atrial fibrillationKarina V Bunting, Simrat K Gill, Alice Sitch, et al.
JAMA|December 22, 2020
Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical TrialDipak Kotecha, Karina V Bunting, Simrat K Gill, et al.
European Heart Journal|January 11, 2023
Artificial intelligence to enhance clinical value across the spectrum of cardiovascular healthcareSimrat K Gill, Andreas Karwath, Hae-Won Uh, et al.
Pageof 1